ArticleBMC medicine2018

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.

Ines Stevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.